Christiani, E.; Naumann, N.; Weiss, C.; Spiess, B.; Kleiner, H.; Fabarius, A.; Hofmann, W.-K.; Saussele, S.; Seifarth, W.
Gene Expression Pattern of ESPL1, PTTG1 and PTTG1IP Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML. Cancers 2023, 15, 2652.
https://doi.org/10.3390/cancers15092652
AMA Style
Christiani E, Naumann N, Weiss C, Spiess B, Kleiner H, Fabarius A, Hofmann W-K, Saussele S, Seifarth W.
Gene Expression Pattern of ESPL1, PTTG1 and PTTG1IP Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML. Cancers. 2023; 15(9):2652.
https://doi.org/10.3390/cancers15092652
Chicago/Turabian Style
Christiani, Eva, Nicole Naumann, Christel Weiss, Birgit Spiess, Helga Kleiner, Alice Fabarius, Wolf-Karsten Hofmann, Susanne Saussele, and Wolfgang Seifarth.
2023. "Gene Expression Pattern of ESPL1, PTTG1 and PTTG1IP Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML" Cancers 15, no. 9: 2652.
https://doi.org/10.3390/cancers15092652
APA Style
Christiani, E., Naumann, N., Weiss, C., Spiess, B., Kleiner, H., Fabarius, A., Hofmann, W. -K., Saussele, S., & Seifarth, W.
(2023). Gene Expression Pattern of ESPL1, PTTG1 and PTTG1IP Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML. Cancers, 15(9), 2652.
https://doi.org/10.3390/cancers15092652